Collegium Pharmaceutical, Inc. (COLL)

NASDAQ: COLL · Real-Time Price · USD

34.92

-2.40 (-6.43%)

At close: Sep 15, 2025, 4:00 PM EDT

34.90

-0.02 (-0.06%)

After-hours: Sep 15, 2025, 4:11 PM EDT

Collegium Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	707.01	631.45	566.77	463.93	276.87	310.02	Upgrade
Revenue Growth (YoY)	22.61%	11.41%	22.17%	67.56%	-10.69%	4.49%	Upgrade
Cost of Revenue	88.3	83.53	79.72	118.19	59.07	69.5	Upgrade
Gross Profit	618.71	547.92	487.05	345.74	217.8	240.52	Upgrade
Selling, General & Admin	247.16	182.98	150.71	172.19	118.96	113.83	Upgrade
Research & Development	-	-	-	3.98	9.45	9.77	Upgrade
Operating Expenses	454.37	348.29	296.47	307.64	195.59	184.28	Upgrade
Operating Income	164.33	199.63	190.58	38.11	22.21	56.23	Upgrade
Interest Expense	-82.3	-73.97	-83.34	-63.21	-21.01	-28.88	Upgrade
Interest & Investment Income	9.7	13.98	15.62	1.05	0.01	0.23	Upgrade
EBT Excluding Unusual Items	91.73	139.63	122.85	-24.06	1.2	27.58	Upgrade
Merger & Restructuring Charges	-37.25	-29.6	-15.12	-	-4.58	-	Upgrade
Asset Writedown	-	-	-	-4.79	-	-	Upgrade
Legal Settlements	-	-	-8.5	-	-	-	Upgrade
Other Unusual Items	-1.48	-11.47	-23.5	-	-	-	Upgrade
Pretax Income	53	98.57	75.73	-28.85	-3.37	27.58	Upgrade
Income Tax Expense	16.73	29.38	27.58	-3.85	-74.89	0.83	Upgrade
Net Income	36.27	69.19	48.16	-25	71.52	26.75	Upgrade
Net Income to Common	36.27	69.19	48.16	-25	71.52	26.75	Upgrade
Net Income Growth	-63.69%	43.68%	-	-	167.33%	-	Upgrade
Shares Outstanding (Basic)	32	32	34	34	35	34	Upgrade
Shares Outstanding (Diluted)	40	40	42	34	41	35	Upgrade
Shares Change (YoY)	-11.15%	-3.26%	23.53%	-17.58%	16.77%	5.07%	Upgrade
EPS (Basic)	1.13	2.14	1.43	-0.74	2.05	0.78	Upgrade
EPS (Diluted)	1.06	1.86	1.29	-0.74	1.86	0.76	Upgrade
EPS Growth	-56.39%	43.56%	-	-	144.25%	-	Upgrade
Free Cash Flow	201.81	203.33	274.29	122.61	101.61	88.4	Upgrade
Free Cash Flow Per Share	5.07	5.03	6.56	3.62	2.48	2.52	Upgrade
Gross Margin	87.51%	86.77%	85.93%	74.52%	78.66%	77.58%	Upgrade
Operating Margin	23.24%	31.61%	33.63%	8.21%	8.02%	18.14%	Upgrade
Profit Margin	5.13%	10.96%	8.50%	-5.39%	25.83%	8.63%	Upgrade
Free Cash Flow Margin	28.54%	32.20%	48.39%	26.43%	36.70%	28.51%	Upgrade
EBITDA	375.77	368.79	339.83	172.26	91.12	117.78	Upgrade
EBITDA Margin	53.15%	58.40%	59.96%	37.13%	32.91%	37.99%	Upgrade
D&A For EBITDA	211.43	169.16	149.26	134.15	68.92	61.55	Upgrade
EBIT	164.33	199.63	190.58	38.11	22.21	56.23	Upgrade
EBIT Margin	23.24%	31.61%	33.63%	8.21%	8.02%	18.14%	Upgrade
Effective Tax Rate	31.56%	29.80%	36.41%	-	-	3.01%	Upgrade
Advertising Expenses	-	10.66	7.41	11.74	4.19	5.37	Upgrade

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q